NASD | Health Care | Pharmaceuticals

Abeona Therapeutics Inc. (ABEO)

LAST (31 Mar)
4.76
-0.21  (-4.23%)
After-Hours (17:57:21 ET)
4.88
+0.12  (+2.52%)
MARKET CAP
228.480 M
VOLUME
867,546
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 31 Mar
Open 4.91
Previous Close 4.97
Day Range 4.68 - 4.96
52-Week Range 3.05 - 8.45
All-Time High 59,375.00
Avg. Volume (50-day) 355,415.62
EPS (TTM) -2.25
Next Earnings Date 2025-05-15 (BMO)
Last Earnings Date 2025-03-20
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -2.21
PEG Ratio -
Price to Book 5.15
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) -
Revenue per Share (TTM) -
Shares Outstanding 48.534 M
Share Float (%) 42.86 M (88.30%)
% Held by Institutions 64.23
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 5.15 (-7.57%)
+/- SMA(50) 5.39 (-11.69%)
+/- SMA(200) 5.54 (-14.08%)
5-Day Perf. -7.03%
1-Month Perf. -9.16%
3-Month Perf. -14.54%
6-Month Perf. -24.68%
YTD Perf. -14.54%
1-Year Perf. -34.34%
RSI(14) 32.91
ATR(14) 0.26
ADX(14) 12.47
Beta (5Y) 0.81
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

ABEO

39.8
(-4.0)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Abeona Therapeutics Inc.

6555 Carnegie Avenue, 4th floor
Cleveland, Ohio
http://www.abeonatherapeuti...
Sector: Health Care
Industry: Pharmaceuticals
Employees: 136
Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Predefined Scans with ABEO View All  
Alerts for ABEO View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with ABEO

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.